NYPOZI
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
69097-430 -
Package NDC
69097-430-67 -
Package NDC
69097-430-96 -
Application number
BLA761126 -
SPL ID
6951a2d4-8d07-4197-a02c-2e5aed420f33 -
SPL set ID
575d164d-45fa-4e3e-81e4-2652d96673d1 -
UNII
PVI5M0M1GW -
RxCUI
2700369 -
RxCUI
2700376 -
RxCUI
2700378 -
RxCUI
2700379
What the source publishes
- Labeler
- Cipla USA Inc.
- Active ingredients
- filgrastim-txid
- Form
- INJECTION
- Routes
- INTRAVENOUS, SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "NYPOZI",
"splId": "6951a2d4-8d07-4197-a02c-2e5aed420f33",
"labels": [
{
"setId": "575d164d-45fa-4e3e-81e4-2652d96673d1",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=575d164d-45fa-4e3e-81e4-2652d96673d1",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=575d164d-45fa-4e3e-81e4-2652d96673d1"
}
],
"routes": [
"INTRAVENOUS",
"SUBCUTANEOUS"
],
"labeler": "Cipla USA Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 SYRINGE, GLASS in 1 CARTON (69097-430-67) / 300 ug in 1 SYRINGE, GLASS",
"package_ndc": "69097-430-67",
"identifierStatus": "well-formed",
"marketing_start_date": "20260211"
},
{
"sample": false,
"description": "10 SYRINGE, GLASS in 1 CARTON (69097-430-96) / 300 ug in 1 SYRINGE, GLASS",
"package_ndc": "69097-430-96",
"identifierStatus": "well-formed",
"marketing_start_date": "20260211"
}
],
"productId": "69097-430_6951a2d4-8d07-4197-a02c-2e5aed420f33",
"useDomain": "unknown",
"dosageForm": "INJECTION",
"productNdc": "69097-430",
"deaSchedule": null,
"genericName": "filgrastim-txid",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "FILGRASTIM",
"strength": "300 ug/300ug"
}
],
"applicationNumber": "BLA761126",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260211",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"M0024696",
"N0000009451",
"N0000175666"
],
"unii": [
"PVI5M0M1GW"
],
"rxcui": [
"2700369",
"2700376",
"2700378",
"2700379"
],
"spl_set_id": [
"575d164d-45fa-4e3e-81e4-2652d96673d1"
],
"pharm_class_cs": [
"Granulocyte Colony-Stimulating Factor [CS]"
],
"pharm_class_pe": [
"Increased Myeloid Cell Production [PE]"
],
"pharm_class_epc": [
"Leukocyte Growth Factor [EPC]"
],
"manufacturer_name": [
"Cipla USA Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:69097-430_6951a2d4-8d07-4197-a02c-2e5aed420f33"